User profiles for Juan José Yepes-Nuñez
Juan José Yepes-Nuñez • MD. MSc. PhD.Assistant Professor at Universidad de los Andes (Colombia) / Fundación Santa Fe de … Verified email at uniandes.edu.co Cited by 9829 |
[HTML][HTML] Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas
…, P Whiting, D Moher, JJ Yepes-Nuñez… - Revista española de …, 2021 - Elsevier
… de los autores (JJ Yepes-Nuñez) preparó una primera versión … y aprobadas por dos
autores (JJ Yepes-Nuñez y S. Alonso-… entre los dos autores Yepes-Nuñez y S. Alonso-Fernández. …
autores (JJ Yepes-Nuñez y S. Alonso-… entre los dos autores Yepes-Nuñez y S. Alonso-Fernández. …
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Declaración PRISMA 2020: una guía actualizada para la publicación de …
JJ Yepes-Nuñez, G Urrutia, M Romero-Garcia… - Revista espanola de …, 2021 - ddd.uab.cat
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement,
published in 2009, was designed to help systematic reviewers transparently report why …
published in 2009, was designed to help systematic reviewers transparently report why …
Calidad de vida en pacientes con enfermedad renal crónica sin diálisis ni trasplante de una muestra aleatoria de dos aseguradoras en salud: Medellín, Colombia …
…, MH Cuellar Santaella, JJ Yepes Nuñez… - Nefrología …, 2009 - SciELO Espana
Objetivo: Estimar la calidad de vida en pacientes con enfermedad renal crónica, que no
han recibido ni diálisis ni trasplante, y su asociación con factores de riesgo. Diseño: Estudio …
han recibido ni diálisis ni trasplante, y su asociación con factores de riesgo. Diseño: Estudio …
[HTML][HTML] Impacto de la inmunoterapia subcutánea con Dermatophagoides farinae y Dermatophagoides pteronyssinus sobre la calidad de vida de pacientes con rinitis …
JJ Yepes-Núñez, C Gómez, Y Espinoza, R Cardona - Biomédica, 2014 - scielo.org.co
YEPES-NUNEZ, Juan José; GOMEZ, Carolina; ESPINOZA, Yeinis and CARDONA, Ricardo.
Impacto de la inmunoterapia subcutánea con Dermatophagoides farinae y …
Impacto de la inmunoterapia subcutánea con Dermatophagoides farinae y …
Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials
…, A Fiocchi, R Pawankar, JJ Yepes-Nuñez… - Journal of Allergy and …, 2015 - Elsevier
Background Allergic diseases are considered a health burden because of their high and
constantly increasing prevalence, high direct and indirect costs, and undesirable effects on …
constantly increasing prevalence, high direct and indirect costs, and undesirable effects on …
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized …
…, I Neumann, W Wiercioch, JJ Yepes-Nuñez… - Blood …, 2019 - ashpublications.org
Background: Venous thromboembolism (VTE) is a common source of perioperative morbidity
and mortality. Objective: These evidence-based guidelines from the American Society of …
and mortality. Objective: These evidence-based guidelines from the American Society of …
EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
…, EM Varga, RG van Wijk, JJ Yepes‐Nuñez… - Allergy, 2019 - Wiley Online Library
Allergen immunotherapy ( AIT ) has been in use for the treatment of allergic disease for
more than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers …
more than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers …
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
…, M Wickman, W Wiercioch, JJ Yepes-Nuñez… - Journal of Allergy and …, 2017 - Elsevier
Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …
life and school and work performance and is a frequent reason for office visits in general …
[HTML][HTML] World allergy organization-McMaster University guidelines for allergic disease prevention (GLAD-P): probiotics
…, A Vereda-Ortiz, S Waserman, JJ Yepes-Nuñez… - World Allergy …, 2015 - Elsevier
Background Prevalence of allergic diseases in infants, whose parents and siblings do not
have allergy, is approximately 10% and reaches 20–30% in those with an allergic first-degree …
have allergy, is approximately 10% and reaches 20–30% in those with an allergic first-degree …
GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT
…, J Riva, C Bollig, A Moore, JJ Yepes-Nuñez… - Journal of clinical …, 2017 - Elsevier
Background Guideline developers can: (1) adopt existing recommendations from others; (2)
adapt existing recommendations to their own context; or (3) create recommendations de …
adapt existing recommendations to their own context; or (3) create recommendations de …